SerpenSeal, next generation wound management (2025-2026)
Abstract
This project will develop an Indigenous manufactured Spinifex gel in combination with snake venom or bleeding control, SerpenSeal. Enabling capabilities for additive manufacturing with Indigenous Australian industry partner Bulugudu Ltd. to establish both a quality controlled scalable production pipeline of the Spinifex derived nanocellulose, the base material for application to control both surgical and more profuse traumatic bleeding. Progressing development of this innovative concept, from TRL3 to TRL4, facilitating the translation and commercialisation of Australia's cutting-edge research, envisaged to surpass the therapeutic functionality and quality of current healthcare products.
